Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 - PubMed (original) (raw)
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
J Kato et al. Genes Dev. 1993 Mar.
Free article
Abstract
The product (pRb) of the retinoblastoma gene (RB-1) prevents S-phase entry during the cell cycle, and inactivation of this growth-suppressive function is presumed to result from pRb hyperphosphorylation during late G1 phase. Complexes of the cyclin-dependent kinase, cdk4, and each of three different D-type cyclins, assembled in insect Sf9 cells, phosphorylated a pRb fusion protein in vitro at sites identical to those phosphorylated in human T cells. Only D-type cyclins activated cdk4 enzyme activity, whereas cyclins A, B1, and E did not. When Sf9 cells were coinfected with baculovirus vectors encoding human pRb and murine D-type cyclins, cyclins D2 and D3, but not D1, bound pRb with high stoichiometry in intact cells. Introduction of a vector encoding cdk4, together with those expressing pRb and D-type cyclins, induced pRb hyperphosphorylation and dissociation of cyclins D2 and D3, whereas expression of a kinase-defective cdk4 mutant in lieu of the wild-type catalytic subunit yielded ternary complexes. The transcription factor E2F-1 also bound to pRb in insect cells, and coexpression of cyclin D-cdk4 complexes, but neither subunit alone, triggered pRb phosphorylation and prevented its interaction with E2F-1. The D-type cyclins may play dual roles as cdk4 regulatory subunits and as adaptor proteins that physically target active enzyme complexes to particular substrates.
Similar articles
- Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Lukas J, et al. Mol Cell Biol. 1995 May;15(5):2600-11. doi: 10.1128/MCB.15.5.2600. Mol Cell Biol. 1995. PMID: 7739541 Free PMC article. - Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Ewen ME, et al. Cell. 1993 May 7;73(3):487-97. doi: 10.1016/0092-8674(93)90136-e. Cell. 1993. PMID: 8343202 - The D-type cyclins and their role in tumorigenesis.
Peters G. Peters G. J Cell Sci Suppl. 1994;18:89-96. doi: 10.1242/jcs.1994.supplement_18.13. J Cell Sci Suppl. 1994. PMID: 7883799 Review. - D-type cyclins.
Sherr CJ. Sherr CJ. Trends Biochem Sci. 1995 May;20(5):187-90. doi: 10.1016/s0968-0004(00)89005-2. Trends Biochem Sci. 1995. PMID: 7610482 Review.
Cited by
- Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer.
Hao M, Chen X, Zhang T, Shen T, Xie Q, Xing X, Gu H, Lu F. Hao M, et al. Oncol Lett. 2011 Nov;2(6):1203-1211. doi: 10.3892/ol.2011.404. Epub 2011 Sep 2. Oncol Lett. 2011. PMID: 22848289 Free PMC article. - Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging.
Huang CH, Khan P, Xu S, Cohen J, Georgakis GV, Turkman N. Huang CH, et al. Int J Mol Sci. 2024 Jun 22;25(13):6870. doi: 10.3390/ijms25136870. Int J Mol Sci. 2024. PMID: 38999983 Free PMC article. - The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment.
Morrison L, Loibl S, Turner NC. Morrison L, et al. Nat Rev Clin Oncol. 2024 Feb;21(2):89-105. doi: 10.1038/s41571-023-00840-4. Epub 2023 Dec 11. Nat Rev Clin Oncol. 2024. PMID: 38082107 Review. - Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Lu J, Wood D, Ingley E, Koks S, Wong D. Lu J, et al. Mol Biol Rep. 2021 Apr;48(4):3637-3647. doi: 10.1007/s11033-021-06362-5. Epub 2021 Apr 24. Mol Biol Rep. 2021. PMID: 33893924 Review. - Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug.
Li H, Hu P, Zou Y, Yuan L, Xu Y, Zhang X, Luo X, Zhang Z. Li H, et al. Front Oncol. 2023 Jan 31;13:1071415. doi: 10.3389/fonc.2023.1071415. eCollection 2023. Front Oncol. 2023. PMID: 36798821 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous